Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-26 Sale | 2023-09-28 5:30 pm | SANGAMO THERAPEUTICS INC | SGMO | BIOGEN INC. Biogen MA Inc. 10% Owner | 6,000,000 | $0.5 | $3,000,000 | 17,652,466 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-24 Tax Withholding | 2024-02-27 5:14 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH | 4,668 | $1.13 | 196,314 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 7,832 | $1.13 | 836,430 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 10,484 | $1.13 | 846,188 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:12 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 8,927 | $1.13 | 834,578 (Direct) | View |
| 2024-02-24 Tax Withholding | 2024-02-27 5:11 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 40,272 | $1.13 | 2,552,204 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:42 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, HEAD OF RESEARCH | 150,000 | $0 | 200,982 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:42 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | 712,500 | $0 | 844,262 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:41 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | 712,500 | $0 | 843,505 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:40 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | 712,500 | $0 | 856,672 (Direct) | View |
| 2024-01-22 Option Award | 2024-01-24 4:39 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | 2,000,000 | $0 | 2,592,476 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:20 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary | 1,329 | $0.3821 | 126,762 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:19 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer | 1,925 | $0.3821 | 212,471 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:19 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 10,411 | $0.3821 | 592,476 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:18 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer | 1,030 | $0.3821 | 136,270 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:17 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer | 1,329 | $0.3821 | 131,005 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:16 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $0.3821 | 139,172 (Direct) | View |
| 2023-11-25 Tax Withholding | 2023-11-28 4:15 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, Head of Research | 490 | $0.3821 | 50,982 (Direct) | View |
Ownership | 2023-11-28 4:14 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Pooler Amy VP, Head of Research | 0 | $0 | 199,805 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:15 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Fontenot Jason D. SVP, Chief Scientific Officer | 1,029 | $0.77 | 137,300 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:15 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer | 1,925 | $0.77 | 214,396 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:14 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer | 1,329 | $0.77 | 132,334 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Macrae Sandy President, CEO and Director | 10,411 | $0.77 | 602,887 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:13 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $0.77 | 140,634 (Direct) | View |
| 2023-08-25 Tax Withholding | 2023-08-29 4:12 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary | 1,329 | $0.77 | 128,091 (Direct) | View |
| 2023-08-13 Tax Withholding | 2023-08-15 4:55 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary | 864 | $1.08 | 129,420 (Direct) | View |
| 2023-06-25 Tax Withholding | 2023-06-26 4:31 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer | 11,528 | $1.19 | 211,321 (Direct) | View |
| 2023-06-11 Tax Withholding | 2023-06-13 4:55 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Duraibabu Prathyusha SVP, Chief Financial Officer | 864 | $1.19 | 133,663 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:52 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Smith Karen L. Director | 41,650 | $0 | 79,850 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:51 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | PARKER H STEWART Director | 41,650 | $0 | 90,350 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:50 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Meyers James R Director | 41,650 | $0 | 77,350 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:49 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Markels John Director | 41,650 | $0 | 74,134 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:48 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Horn Margaret A Director | 41,650 | $0 | 60,400 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:48 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Hillan Kenneth J. Director | 41,650 | $0 | 77,350 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:47 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Carey Robert Director | 41,650 | $0 | 77,350 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 4:46 pm | N/A 2033-05-31 | SANGAMO THERAPEUTICS INC | SGMO | Beers Courtney Director | 41,650 | $0 | 60,400 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:45 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Willoughby Scott B. SVP, Gen. Counsel & Secretary | 1,328 | $1.33 | 125,284 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:44 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Ramelmeier Rolf Andrew EVP, Technical Operations | 1,750 | $1.33 | 171,467 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:43 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | McClung David Mark EVP, Chief Operating Officer | 1,925 | $1.33 | 222,849 (Direct) | View |
| 2023-05-25 Tax Withholding | 2023-05-30 4:43 pm | N/A N/A | SANGAMO THERAPEUTICS INC | SGMO | Dubois-Stringfellow Nathalie SVP-Chief Development Officer | 1,462 | $1.33 | 137,096 (Direct) | View |